Dr Reddy's gets EIR for Vizag plant, but inspection not closed Ruby Khatun Khatun22 Nov 2017 11:06 AM ISTNew Delhi: Dr. Reddy's Laboratories said it has received an establishment inspection report (EIR) from the US health regulator for its formulation...
Dr Reddys receives EIR for Srikakulam plant, shares soar Ruby Khatun Khatun22 Sept 2017 10:29 AM ISTNew Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the...
Dr Reddys launches antidepressant, muscle relaxant tablets in US Ruby Khatun Khatun7 Sept 2017 11:19 AM ISTNew Delhi: Dr. Reddy's Laboratories on Wednesday said it has launched Bupropion Hydrochloride extended-release tablets used in treating a major...
Dr Reddys out-licenses steroid DFD-06 to Encore Dermatology Ruby Khatun Khatun24 Aug 2017 11:00 AM ISTNew Delhi: Drug major Dr Reddy's Laboratories on Tuesday said it has out-licensed the future development, manufacturing and commercialisation rights...
Dr Reddys launches anti-fungal ointment in the US supriya kashyap kashyap6 Dec 2016 11:22 AM ISTNew Delhi : Dr Reddy's Laboratories Ltd announced the launch of anti-fungal ointment nystatin and triamcinolone acetonide in the US market.In a BSE...
Dr Reddy Labs inks pact with Amgen to market three drugs in India savita thakur thakur18 Sept 2016 9:34 AM ISTHyderabad : Dr Reddy's Laboratories (DRL) has expanded its strategic collaboration with US based independent biotechnology firm Amgen to market and...
Indian Pharma companies biggest violators of USFDA integrity norms Geeta Sharma Sharma7 May 2016 3:35 PM IST Mumbai:Sixty percent of reported data integrity violations in the records of US regulator since 2011 are against drug manufacturing units in...
